ArticleScientific reports2025
Risk prediction model development for requiring unplanned psychiatric readmission in bipolar disorder.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The high readmission rate of bipolar disorder (BD) has imposed a heavy burden on the country and patients. Current studies mainly examine readmission influence factors but neglect risk prediction models. This study aims to develop a prediction model requiring unplanned psychiatric readmissions (RUPR) within 1 year of BD. We screened the third people's hospital of tianshui inpatients between January 1, 2021 and November 10, 2023 via hospital records and phone follow-ups, collecting required participant data. Based on their demographic and scale score, multiple variable logistic regression analysis was used to develop a nomogram-based prediction model. The study included 448 cases with 153 events. The analysis results show that group comparison revealed a significant difference in gender distribution, age stratification, comorbid chronic somatic diseases (CSD), partnered status (PS), social support rating scale (SSRS) scores, insight and treatment attitude questionnaire (ITAQ) scores, modified overt aggression scale (MOAS) scores. The result of multiple variable logistic regression analysis indicates that male gender and comorbid CSD increased readmission risk; Age > 60 years decreased risk; Higher MOAS scores, lower SSRS scores and ITAQ scores were significantly associated with elevated readmission risk. Model evaluation demonstrated that area under the receiver operating characteristic curve was 0.85(95% CI 0.81-0.89) ; Hosmer-Lemeshow test (χ2 = 6.15, P = 0.63) indicates a good fit. This prediction model helps identify high-risk cases and simplifies BD management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.